Hemorrhagic stroke associated with antidepressant use in patients with depression: does degree of serotonin reuptake inhibition matter?
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Objective: This study aimed to determine whether the degree of serotonin (5‐HT) reuptake inhibition affects risk of hemorrhagic stroke associated with antidepressant use in patients with depression. Method: A population‐based, nested case‐control study was performed using a managed care medical claims database. Ninety two depressed patients with a diagnosis of hemorrhagic stroke were identified and matched with 552 controls by age, sex, and year of index date of depression (IDD). Diagnoses of depression, hemorrhagic stroke, and other medical comorbidities were identified using ICD‐9 codes. Antidepressants were classified as high, medium, or low reuptake inhibition based on their affinities for the 5‐HT reuptake transporter, determined using their respective equilibrium dissociation constants (KD; high: KD < 1 nM; medium: 1 ≤ KD < 10 nM; low: KD ≥ 10 nM). Conditional logistic regression analysis was performed to estimate the crude and adjusted odds ratios (ORs) with 95% confidence intervals (CIs) of the risk of hemorrhagic stroke. Results: Compared to non‐users of antidepressants, risk of hemorrhagic stroke did not significantly differ between patients who had ever used antidepressants with high (OR = 0.82; 95% CI = 0.44–1.55), medium (OR = 0.93; 95% CI = 0.37–2.31), or low (OR = 0.38; 95% CI = 0.11–1.41) 5‐HTT inhibition. Conclusion: Risk of hemorrhagic stroke associated with antidepressant use may not be related to an antidepressant's degree of 5‐HT reuptake inhibition. Given the limitations of this study, additional studies are needed to confirm these findings. Copyright © 2009 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pharmacological profile of antidepressants and related compounds at human monoamine transporters
Tatsumi, M., Groshan, K., Blakely, R. D., & Richelson, E. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01393-9 · Cited by 939
Cited by
Andrade, S. E., Harrold, L. R., Tjia, J., Cutrona, S. L., Saczynski, J. S., Dodd, K. S., Goldberg, R. J., & Gurwitz, J. H. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2312 · Cited by 268
de Abajo, F. J. (2011) · Drugs & Aging · doi:10.2165/11589340-000000000-00000 · Cited by 206
Douros, A., Ades, M., & Renoux, C. (2018) · CNS Drugs · doi:10.1007/s40263-018-0507-7 · Cited by 42
“Among the five studies that addressed the risk of ICH associated with the strength of inhibition of serotonin reuptake, two were nested case-control studies [14, 15], one was a cohort study [13], one was a case-control study [16], and one was a case-crossover study [17].”
BackgroundResultInfluentialAntidepressant use and risk of coronary heart disease: meta‐analysis of observational studies
Oh, S., Kim, J., Myung, S., Hwang, S., & Yoon, D. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12383 · Cited by 40
Metadata
- Authors
- Chen, Y., Guo, J. J., & Patel, N. C.
- Venue
- Pharmacoepidemiology and Drug Safety
- Publisher
- Wiley
- Published
- 2008-12-30
- Volume
- 18
- Issue
- 3
- Pages
- 196-202
- ISSN
- 1053-8569 (ISSN-L)
- 1099-1557
- OpenAlex
- W2044985231
- Cited by
- 33
- References
- 1
- FWCI
- 2.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hemorrhagic stroke associated with antidepressant use in patients with depression: does degree of serotonin reuptake inhibition matter? https://app.cochat.ai/papers/10.1002/pds.1699
- The paper
- Chen, Y., Guo, J. J., & Patel, N. C. (2009). Hemorrhagic stroke associated with antidepressant use in patients with depression: does degree of serotonin reuptake inhibition matter? Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.1699
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.